HC ANDERSEN CAPITAL

Main Menu

HC ANDERSEN CAPITAL

INDERES
CONTACT

ALK – Opdatering på de første 9 måneder i 2024 og ny strategisk licensaftale med ARS Pharma

AUTHOR
DATE
11. November 2024
CATEGORY

ALK – Opdatering på de første 9 måneder i 2024 og ny strategisk licensaftale med ARS Pharma

ALK – Opdatering på de første 9 måneder i 2024 og ny strategisk licensaftale med ARS Pharma 18 NovemberNov 2024 11:15 - 19 NovemberNov 2024 11:45Online Event
Tilmeld

Information

ALK – Opdatering på de første 9 måneder i 2024 og ny strategisk licensaftale med ARS Pharma 18 NovemberNov 2024 11:15 - 19 NovemberNov 2024 11:45
ALK – Opdatering på de første 9 måneder i 2024 og ny strategisk licensaftale med ARS Pharma Online Event
Tilmeld

PREVIOUS STORY

NEXT STORY

Explore our services

IR Advisory

Read more

ESG Advisory

Read more

Legal Advisory

Read more

Corporate Finance

Read more

IR Recruitment

Read more

Certified Advisor (CA)

Read more

Commissioned Research

Read more

HCA Media

Read more

IR Distribution Software

Read more

AGM Services

Read more

IR Events

Read more

IR Websites

Read more

Digital IR

Read more

HC ANDERSEN CAPITAL

INFORMATION

Bredgade 23B 2. sal
1260 København K
View on map
Phone: 28 74 66 40
CVR: 41474793

About

What we do

HC Andersen Capital was established in 2020 and is at the forefront of digital Investor Relations, amplifying market presence.

Our tailored services encompass IR and ESG advisory, Legal Support, cutting-edge digital solutions such as IR websites and IR distribution software, Commissioned Research, Corporate Finance advisory and more. We are proudly Certified Advisor on Nasdaq First North Copenhagen.

2024 - HC Andersen Capital

Cookie Policy

Privacy Policy